CC-92252

N/A

Report date: 2024/11/15 14:35:45

Base Information

Drug NameCC-92252

Drug Alias NameDEL-106CC-92252

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein

Mechanisms of ActionInterleukin-2 receptor agonistsRegulatory T-lymphocytes stimulants

TargetsInterleukin-2 receptor

Therapy Area/IndicationsPsoriasis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesCelgene Corp

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCelgene Corp

Active IndicationsN/A

Inactive IndicationsPsoriasis

ATC CodeN/A